PH24515A - Antiparkinson ergoline derivatives - Google Patents

Antiparkinson ergoline derivatives

Info

Publication number
PH24515A
PH24515A PH37837A PH37837A PH24515A PH 24515 A PH24515 A PH 24515A PH 37837 A PH37837 A PH 37837A PH 37837 A PH37837 A PH 37837A PH 24515 A PH24515 A PH 24515A
Authority
PH
Philippines
Prior art keywords
antiparkinson
ergoline derivatives
ergoline
derivatives
antiparkinson ergoline
Prior art date
Application number
PH37837A
Other languages
English (en)
Inventor
Metilde Buonamici
Lorenzo Pegrassi
Alessandro Rossi
Sergio Mantegani
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878727236A external-priority patent/GB8727236D0/en
Priority claimed from GB888822424A external-priority patent/GB8822424D0/en
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of PH24515A publication Critical patent/PH24515A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH37837A 1987-11-20 1988-11-18 Antiparkinson ergoline derivatives PH24515A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878727236A GB8727236D0 (en) 1987-11-20 1987-11-20 Antiparkinson ergoline derivatives
GB888822424A GB8822424D0 (en) 1988-09-23 1988-09-23 Antiparkinson ergoline derivatives

Publications (1)

Publication Number Publication Date
PH24515A true PH24515A (en) 1990-07-18

Family

ID=26293081

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37837A PH24515A (en) 1987-11-20 1988-11-18 Antiparkinson ergoline derivatives

Country Status (20)

Country Link
US (1) US4847253A (xx)
EP (1) EP0317269B1 (xx)
JP (1) JP2655706B2 (xx)
KR (1) KR890007738A (xx)
CN (1) CN1033182A (xx)
AU (1) AU602268B2 (xx)
CA (1) CA1312015C (xx)
DE (1) DE3868866D1 (xx)
DK (1) DK645788A (xx)
ES (1) ES2032570T3 (xx)
FI (1) FI885346A (xx)
GR (1) GR3004355T3 (xx)
HU (1) HU200557B (xx)
IE (1) IE61612B1 (xx)
IL (1) IL88392A (xx)
MY (1) MY103477A (xx)
NO (1) NO885166L (xx)
NZ (1) NZ227022A (xx)
PH (1) PH24515A (xx)
PT (1) PT89036B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69330601T2 (de) * 1992-12-24 2002-07-04 Pharmacia & Upjohn Spa Serotoninergische ergolin derivate
EP0664705B1 (en) * 1993-08-18 2000-10-04 Alcon Laboratories, Inc. Compositions of ergoline derivatives for the treatment of glaucoma
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
GB9407637D0 (en) 1994-04-18 1994-06-08 Erba Carlo Spa Serotoninergic abeo-ergoline derivatives
GB9603226D0 (en) * 1996-02-15 1996-04-17 Pharmacia Spa Heterocyclyl-ergoline derivatives
US6060483A (en) * 1996-06-27 2000-05-09 Pharmacia & Upjohn S.P.A. Antineurodegenerative ergoline derivatives
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US20040048779A1 (en) * 2002-05-06 2004-03-11 Erwin Schollmayer Use of rotigotine for treating the restless leg syndrome
DK1426049T3 (da) * 2002-12-02 2005-08-22 Sanol Arznei Schwarz Gmbh Iontophoretisk tilförsel af rotigotin til behandling af Parkinsons sygdom
EP1547592A1 (en) * 2003-12-23 2005-06-29 Schwarz Pharma Ag Intranasal formulation of rotigotine
DE10361258A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
US20050197385A1 (en) * 2004-02-20 2005-09-08 Schwarz Pharma Ag Use of rotigotine for treatment or prevention of dopaminergic neuron loss
DE102004014841B4 (de) * 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
EP1987815A1 (en) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
GB8501078D0 (en) * 1985-01-16 1985-02-20 Erba Farmitalia Piperazin-1-yl-ergo-line derivatives

Also Published As

Publication number Publication date
AU602268B2 (en) 1990-10-04
NO885166L (no) 1989-05-22
JPH01153689A (ja) 1989-06-15
JP2655706B2 (ja) 1997-09-24
AU2568488A (en) 1989-05-25
IL88392A0 (en) 1989-06-30
FI885346A (fi) 1989-05-21
MY103477A (en) 1993-06-30
HUT48463A (en) 1989-06-28
US4847253A (en) 1989-07-11
GR3004355T3 (xx) 1993-03-31
EP0317269A2 (en) 1989-05-24
NO885166D0 (no) 1988-11-18
IE61612B1 (en) 1994-11-16
KR890007738A (ko) 1989-07-05
PT89036B (pt) 1993-02-26
PT89036A (pt) 1988-12-01
NZ227022A (en) 1991-01-29
EP0317269A3 (en) 1990-05-16
FI885346A0 (fi) 1988-11-18
ES2032570T3 (es) 1993-02-16
IL88392A (en) 1992-01-15
CA1312015C (en) 1992-12-29
IE883453L (en) 1989-05-20
DK645788A (da) 1989-05-21
HU200557B (en) 1990-07-28
CN1033182A (zh) 1989-05-31
EP0317269B1 (en) 1992-03-04
DK645788D0 (da) 1988-11-18
DE3868866D1 (de) 1992-04-09

Similar Documents

Publication Publication Date Title
GR3002864T3 (en) Azolylmethylcyclopropyl derivatives
EP0317269A3 (en) Antiparkinson ergoline derivatives
EP0318704A3 (en) 3-cyano-4-phenyl-pyrrole derivatives
GB8815258D0 (en) Thiorea derivatives
EP0305322A3 (en) Isoxazole-beta-carboline derivatives
ZA899580B (en) Ergoline derivatives
EP0297383A3 (en) Hydroxyethyl-azolyl derivatives
GB2209032B (en) Beta-carboline derivatives
GB8824744D0 (en) Antiemesis ergoline derivatives
GB8810287D0 (en) 2-aryl-4-isoxazolin-3-one derivatives
EP0322164A3 (en) Ethanolamie derivatives
GB8705601D0 (en) Oxo-isoindolinyl derivatives
GB8726272D0 (en) 4-demethoxy anthra-cycline derivatives
GB8709893D0 (en) Ergoline derivatives
GB2200910B (en) Thiopilocarpine derivatives
GB8727236D0 (en) Antiparkinson ergoline derivatives
GB8704236D0 (en) Anthracycline-oestrone derivatives
ZA89640B (en) Ergoline derivatives
GB8822424D0 (en) Antiparkinson ergoline derivatives
GB8700016D0 (en) Quinolizinone derivatives
GB8715925D0 (en) Thiapentanamide derivatives
GB8608127D0 (en) Ergoline derivatives
IE890200L (en) Ergoline derivatives
GB2211840B (en) Indenofuran derivatives
FI103571B1 (fi) Propoksibentseenijohdannaisia